Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-03-09 @ 9:20 AM
Study NCT ID:
NCT00528333
Status:
COMPLETED
Last Update Posted:
2015-01-07
First Post:
2007-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
Sponsor:
Seagen Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-10
First Submit QC Date:
None
Study First Post Date:
2007-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-10-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-12-17
Last Update Post Date:
2015-01-07
Last Update Post Date Type:
ESTIMATED